Symposia
- Date:
- Time: -
- Track: Clinical Practice
- CME/CE: 1.0
Sponsored by the Pharmacists Section
Moderator: Megan Carr, PharmD, BCPS, BCGP
The purpose of this symposium is to educate the audience and summarize the changes over the past year in pharmacotherapy. The speakers will examine information regarding newly approved medications, as well as clinical implications, including potential adverse effects, related to medication formulations. Learning Objectives: (1) communicate the indication for use, mechanism of action, pharmacokinetics, dosing, safety, and drug interactions for newly approved medications; (2) compare potential advantages and disadvantages of incorporating new medications into clinical practice; (3) discuss Medicare Part D and recent industry changes that impact access to and the promotion of medications use that contributes to polypharmacy; and (4) describe community-based models that address both medication access to and the appropriate use of medications.
Newly Approved Medications and Place in Therapy for Older Adults
Hien T. Nguyen, PharmD, BCGP
Medicare and Medication Optimization: Navigating Access and Appropriate Use
Gina Upchurch, RPh, MPH